393 related articles for article (PubMed ID: 9212062)
21. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
22. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
[TBL] [Abstract][Full Text] [Related]
23. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.
Wei P; Inamdar N; Vedeckis WV
Mol Endocrinol; 1998 Sep; 12(9):1322-33. PubMed ID: 9731701
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
25. Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription.
Voss TC; John S; Hager GL
Mol Endocrinol; 2006 Nov; 20(11):2641-55. PubMed ID: 16873444
[TBL] [Abstract][Full Text] [Related]
26. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation.
Ray DW; Suen CS; Brass A; Soden J; White A
Mol Endocrinol; 1999 Nov; 13(11):1855-63. PubMed ID: 10551779
[TBL] [Abstract][Full Text] [Related]
27. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
Ray A; LaForge KS; Sehgal PB
Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715
[TBL] [Abstract][Full Text] [Related]
28. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
[TBL] [Abstract][Full Text] [Related]
29. Failure of steroid regulation of the MMTV promoter in a small cell lung cancer cell line is caused by a DNA sequence flanking the glucocorticoid response element.
Huynh TT; Ray DW; Brogan IJ; Stevens A; Davis JR; White A; White A
J Endocrinol; 2002 Feb; 172(2):295-302. PubMed ID: 11834447
[TBL] [Abstract][Full Text] [Related]
30. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
Härtig E; Cato AC
Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
[TBL] [Abstract][Full Text] [Related]
31. The promoter context determines mutual repression or synergism between NF-kappaB and the glucocorticoid receptor.
Hofmann TG; Schmitz ML
Biol Chem; 2002 Dec; 383(12):1947-51. PubMed ID: 12553732
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element.
Alcorn JL; Islam KN; Young PP; Mendelson CR
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L767-76. PubMed ID: 14633512
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
[TBL] [Abstract][Full Text] [Related]
34. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
35. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1.
Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193
[TBL] [Abstract][Full Text] [Related]
36. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter.
Novac N; Baus D; Dostert A; Heinzel T
FASEB J; 2006 Jun; 20(8):1074-81. PubMed ID: 16770006
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
Charmandari E; Kino T; Ichijo T; Zachman K; Alatsatianos A; Chrousos GP
J Clin Endocrinol Metab; 2006 Apr; 91(4):1535-43. PubMed ID: 16449337
[TBL] [Abstract][Full Text] [Related]
38. High level expression of wild type and variant mouse glucocorticoid receptors in Chinese hamster ovary cells.
Hirst MA; Northrop JP; Danielsen M; Ringold GM
Mol Endocrinol; 1990 Jan; 4(1):162-70. PubMed ID: 2157974
[TBL] [Abstract][Full Text] [Related]
39. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
Ray A; LaForge KS; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells.
Chen Y; Nickola TJ; DiFronzo NL; Colberg-Poley AM; Rose MC
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):338-47. PubMed ID: 16239644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
